Delivery Order SPE2DB24D2012-SPE2DB25FBVAL

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $80,881.71, is for the delivery of SPRYCEL 70 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of August 2, 2022 and is a firm fixed-price delivery order. This award appears to be part of a larger Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,877.61, is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of December 20, 2024. This award is not designated as a set-aside contract. In addition to this specific delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,590.80 firm-fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of June 13, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRYCEL 50 MG TABLET 60S. The $16,175.25 firm fixed price contract has a completion date of August 29, 2024. This award is a part of a larger Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 80 MG TABLET 30S, a prescription medication, with a ceiling value of $30,541.07 and a period of performance through November 7, 2024. The contract is a firm-fixed-price type, with no set-aside designation indicated. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,188.64 Firm Fixed Price Delivery Order is for the supply of SPRYCEL 100 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $46,211.20 Firm Fixed Price delivery order is for the supply of 4,566,144,081 SPRYCEL 100 MG Tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply SPRYCEL 100 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $20,097.49 and a performance period ending on September 16, 2024. It is a firm-fixed-price contract and does not have any set-aside designations. This delivery order is part of a larger indefinite delivery contract (IDC) between...
This is a federal contract award made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The award ceiling value is $77,565.92 and the contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,391.74, is for the delivery of SPRYCEL 50 MG TABLET 60S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 21, 2024. The contract was not designated with a set-aside requirement, indicating open competition....
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVAL
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 70 MG TABLET 60S, valued at $12,196.84. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 9:49 AM